CAR T-cell therapy in Turkey
CAR T-cell Therapy
With the advancement of science in treating certain cancers and after conducting extensive studies on the latest methods for treating lymphomas, leukemia, and other types of cancer based on the patient’s condition, we have reached an advanced level of research in treating these tumors at our hospital, achieving a success rate of 95%.
CAR T-cell therapy is a type of immunotherapy. You may also hear it referred to as a form of adoptive cell transfer.
This therapy is highly complex and specialized. Using this treatment, a specialist collects your T-cells and makes small changes to them. After a few weeks, you receive a solution containing these cells back into your bloodstream. The CAR T-cells then recognize and attack cancer cells.
It is available as a potential treatment for some children with leukemia and some adults with lymphoma. People with other types of cancer may receive it as part of a clinical trial.
Understanding CAR T-cell Therapy
To better understand CAR T-cell therapy, it’s useful to know the function of T-cells.
White blood cells known as lymphocytes play a significant role in fighting infections and diseases, including cancer. There are different types of lymphocytes, and T-cells are one type.
CAR T-cells move throughout the body to find and destroy damaged cells. When they come into contact with a new infection or disease, the body produces T-cells to fight that specific infection or disease. It then retains some in reserve so that if it encounters the infection again, your body can recognize and attack it immediately.
What is CAR T-cell Therapy?
T-cells are good at combating infections, but they may find it difficult to distinguish between cancerous cells and normal cells. Therefore, cancer cells can sometimes evade detection.
Scientists are trying to find ways to make T-cells recognize cancer cells. CAR T-cell therapy is one of the possible ways to achieve this.
How Does CAR T-cell Therapy Work?
Our medical team takes a sample of your T-cells from your blood. This process is called apheresis.
In the laboratory, we modify the T-cells. You may hear this referred to as genetic engineering of T-cells. The T-cell is now a CAR T-cell. CAR stands for chimeric antigen receptor. These CAR T-cells are designed to recognize and target a specific protein found on cancer cells.
These modified T-cells grow and multiply in the lab. Once there are enough CAR T-cells, you receive a drop containing these cells back into your bloodstream. The goal is for CAR T-cells to recognize and attack the cancer cells.
The modifications made in the lab mean they can remain in your body for extended periods, recognizing and attacking specific cancer cells. Researchers are still investigating how long they may last in the body.
Who Can Receive CAR T-cell Therapy?
CAR T-cell therapy is available for some children with leukemia and certain adults with lymphoma.
Side Effects of CAR T-cell Therapy
This is a new treatment, so doctors may not yet know all potential side effects. Known side effects include:
- Allergic Reactions
- Cytokine Release Syndrome
- Neurological Changes (Neurotoxicity)
- Elevated Uric Acid Levels in the Blood, due to rapid breakdown of cancer cells.
The medical team monitors you closely during and after treatment for any signs of these side effects.